InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lawson Byron, Directeur Commercial. Director active across 1 company, notably HTG Molecular Diagnostics, INC. Aggregated, 14 filings have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
1,000 shares@ US$0.4254.2% of flowCommon StockSEC:0001209191-22-061009:0
23 shares@ US$1.030.2% of flowCommon StockSEC:0001209191-22-040341:0
1,000 shares@ US$0.4764.9% of flowCommon StockSEC:0001209191-22-036956:0
23 shares@ US$1.390.3% of flowCommon StockSEC:0001209191-22-022392:0
24 shares@ US$5.421.2% of flowCommon StockSEC:0001209191-22-000857
24 shares@ US$5.421.3% of flowCommon StockSEC:0001209191-22-000857:0
896 shares@ US$3.561530.9% of flowCommon StockSEC:0001209191-21-069780:0
896 shares@ US$3.561529.6% of flowCommon StockSEC:0001209191-21-069780
24 shares@ US$5.711.3% of flowCommon StockSEC:0001209191-21-058992:0
24 shares@ US$5.711.2% of flowCommon StockSEC:0001209191-21-058992
24 shares@ US$5.811.2% of flowCommon StockSEC:0001209191-21-045190
24 shares@ US$5.811.3% of flowCommon StockSEC:0001209191-21-045190:0
354 shares@ US$3.918512.5% of flowCommon StockSEC:0001209191-21-040446:0
354 shares@ US$3.918512.0% of flowCommon StockSEC:0001209191-21-040446
14 of 14 declarations
About Lawson Byron
Byron Lawson is Senior Vice President and Chief Commercial Officer at HTG Molecular Diagnostics, Inc. He oversees commercial operations, playing a key role in growth strategy and business development.
